Skip to main content

Advertisement

SpringerLink
Log in

Whole-body MRI in assessing malignant transformation in multiple hereditary exostoses and enchondromatosis: audit results and literature review

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

A Correction to this article was published on 27 December 2019

This article has been updated

Abstract

Objective

To analyze the results of annual screening using whole-body magnetic resonance imaging (WBMRI) in patients with multiple hereditary exostoses (MHE) and enchondromatosis (EC), and estimate the risk for transformation to chondrosarcoma (CS) in these disorders.

Materials and methods

A total of 62 patients (57 with MHE and five with EC) screened during a mean follow-up period of 4.6 years (range, 1–10 years) using 253 WBMRIs (median four WBMRIs per patient, range, 1–10) were analyzed retrospectively. The time of WBMRIs was compared with dates for diagnosed CSs. A supplementary literature review was performed focusing on the risk of malignant transformation.

Results

Ten patients had CS before being enrolled in the screening program, nine with MHE and one with EC. Three asymptomatic CSs were detected by screening; one in a patient with EC and two in patients with MHE, one of whom had CS previously. During the screening period, there was no occurrence of CS not detected by WBMRI in the study group.

Histopathologically, the CSs were predominantly grade 1 and were, except for in two patients, located at the truncus, proximal femur, and shoulder girdle.

Based on the current material and literature review, the risk of CS seems to be in the range of 2–3.7% for MHE and up to 50% for EC patients.

Conclusions

MRI may be used as a screening method detecting malignant transformation in MHE and EC patients, but the efficacy has to be confirmed in long-term follow-up studies including cost analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Change history

  • 27 December 2019

    Unfortunately in Volume 49, Issue 1 had been published online with an incorrect date (2001 instead of 2020).

References

  1. Altay M, Bayrakci K, Yildiz Y, Erekul S, Saglik Y. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients. J Orthop Sci. 2007;12(5):415–23.

    Article  Google Scholar 

  2. Black B, Dooley J, Pyper A, Reed M. Multiple hereditary exostoses. An epidemiologic study of an isolated community in Manitoba. Clin Orthop Relat Res. 1993;287(287):212–7.

    Google Scholar 

  3. Brien EW, Mirra JM, Luck JV. Jr. benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. II. Juxtacortical cartilage tumors. Skelet Radiol. 1999;28(1):1–20.

    Article  CAS  Google Scholar 

  4. Clement ND, Ng CE, Porter DE. Shoulder exostoses in hereditary multiple exostoses: probability of surgery and malignant change. J Shoulder Elb Surg. 2011;20(2):290–4.

    Article  Google Scholar 

  5. Czajka CM, DiCaprio MR. What is the proportion of patients with multiple hereditary exostoses who undergo malignant degeneration? Clin Orthop Relat Res. 2015;473(7):2355–61.

    Article  Google Scholar 

  6. Gordon SL, Buchanan JR, Ladda RL. Hereditary multiple exostoses: report of a kindred. J Med Genet. 1981;18(6):428–30.

    Article  CAS  Google Scholar 

  7. Crandall BF, Field LL, Sparkes RS, Spence MA. Hereditary multiple exostoses. Report of a family. Clin Orthop Relat Res. 1984;190(190):217–9.

    Google Scholar 

  8. Goud AL, de Lange J, Scholtes VA, Bulstra SK, Ham SJ. Pain, physical and social functioning, and quality of life in individuals with multiple hereditary exostoses in the Netherlands: a national cohort study. J Bone Joint Surg Am. 2012;94(11):1013–20.

    Article  CAS  Google Scholar 

  9. Kivioja A, Ervasti H, Kinnunen J, Kaitila I, Wolf M, Bohling T. Chondrosarcoma in a family with multiple hereditary exostoses. J Bone Joint Surg Br. 2000;82(2):261–6.

    Article  CAS  Google Scholar 

  10. Francannet C, Cohen-Tanugi A, Le Merrer M, Munnich A, Bonaventure J, Legeai-Mallet L. Genotype-phenotype correlation in hereditary multiple exostoses. J Med Genet. 2001;38(7):430–4.

    Article  CAS  Google Scholar 

  11. Pedrini E, Jennes I, Tremosini M, et al. Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of "protective" and "risk" factors. J Bone Joint Surg Am. 2011;93(24):2294–302.

    Article  Google Scholar 

  12. Pierz KA, Stieber JR, Kusumi K, Dormans JP. Hereditary multiple exostoses: one center’s experience and review of etiology. Clin Orthop Relat Res. 2002;401(401):49–59.

    Article  Google Scholar 

  13. Porter DE, Lonie L, Fraser M, et al. Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J Bone Joint Surg Br. 2004;86(7):1041–6.

    Article  CAS  Google Scholar 

  14. Schmale GA, Conrad EU 3rd, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 1994;76(7):986–92.

    Article  CAS  Google Scholar 

  15. Wicklund CL, Pauli RM, Johnston D, Hecht JT. Natural history study of hereditary multiple exostoses. Am J Med Genet. 1995;55(1):43–6.

    Article  CAS  Google Scholar 

  16. Vanhoenacker FM, Van Hul W, Wuyts W, Willems PJ, De Schepper AM. Hereditary multiple exostoses: from genetics to clinical syndrome and complications. Eur J Radiol. 2001;40(3):208–17.

    Article  CAS  Google Scholar 

  17. Tong K, Liu H, Wang X, et al. Osteochondroma: review of 431 patients from one medical institution in South China. J Bone Oncol. 2017;8:23–9.

    Article  Google Scholar 

  18. Voutsinas S, Wynne-Davies R. The infrequency of malignant disease in diaphyseal aclasis and neurofibromatosis. J Med Genet. 1983;20(5):345–9.

    Article  CAS  Google Scholar 

  19. Liu J, Hudkins PG, Swee RG, Unni KK. Bone sarcomas associated with Ollier’s disease. Cancer. 1987;59(7):1376–85.

    Article  CAS  Google Scholar 

  20. Brien EW, Mirra JM, Kerr R. Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I The intramedullary cartilage tumors. Skeletal Radiol. 1997;26(6):325–53.

    Article  CAS  Google Scholar 

  21. Verdegaal SH, Bovee JV, Pansuriya TC, et al. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011;16(12):1771–9.

    Article  Google Scholar 

  22. Hameetman L, Bovee JV, Taminiau AH, Kroon HM, Hogendoorn PC. Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management. Hered Cancer Clin Pract. 2004;2(4):161–73.

    Article  Google Scholar 

  23. Gariani J, Westerland O, Natas S, Verma H, Cook G, Goh V. Comparison of whole-body magnetic resonance imaging (WBMRI) to whole-body computed tomography (WBCT) or (18)F-fluorodeoxyglucose positron emission tomography/CT ((18)F-FDG PET/CT) in patients with myeloma: systematic review of diagnostic performance. Crit Rev Oncol Hematol. 2018;124:66–72.

    Article  Google Scholar 

  24. Sampath Kumar V, Tyrrell PN, Singh J, Gregory J, Cribb GL, Cool P. Surveillance of intramedullary cartilage tumours in long bones. Bone Joint J. 2016;98-B(11):1542–7.

    Article  CAS  Google Scholar 

  25. Anupindi SA, Bedoya MA, Lindell RB, et al. Diagnostic performance of whole-body MRI as a tool for Cancer screening in children with genetic Cancer-predisposing conditions. AJR Am J Roentgenol. 2015;205(2):400–8.

    Article  Google Scholar 

  26. Greer MC, Voss SD, States LJ. Pediatric cancer predisposition imaging: focus on whole-body MRI. Clin Cancer Res. 2017;23(11):e6–e13.

    Article  Google Scholar 

  27. Saya S, Killick E, Thomas S, Taylor N, Bancroft EK, Rothwell J, et al. Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls. Familial Cancer. 2017;16(3):433–40.

    Article  CAS  Google Scholar 

  28. Bernard SA, Murphey MD, Flemming DJ, Kransdorf MJ. Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging. Radiology. 2010;255(3):857–65.

    Article  Google Scholar 

  29. Ahmed AR, Tan TS, Unni KK, Collins MS, Wenger DE, Sim FH. Secondary chondrosarcoma in osteochondroma: report of 107 patients. Clin Orthop Relat Res. 2003;(411):193–206 doi(411):193–206.

    Article  Google Scholar 

  30. Sonne-Holm E, Wong C, Sonne-Holm S. Multiple cartilaginous exostoses and development of chondrosarcomas—a systematic review. Dan Med J. 2014;61(9):A4895.

    PubMed  Google Scholar 

  31. Pansuriya TC, Kroon HM, Bovee JV. Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol. 2010;3(6):557–69.

    PubMed  PubMed Central  Google Scholar 

  32. Wuisman PI, Jutte PC, Ozaki T. Secondary chondrosarcoma in osteochondromas. Medullary extension in 15 of 45 cases. Acta Orthop Scand. 1997;68(4):396–400.

    Article  CAS  Google Scholar 

  33. Goud AL, Wuyts W, Bessems J, Bramer J, van der Woude HJ, Ham J. Intraosseous atypical chondroid tumor or chondrosarcoma grade 1 in patients with multiple osteochondromas. J Bone Joint Surg Am. 2015;97(1):24–31.

    Article  Google Scholar 

  34. Hendel HW, Daugaard S, Kjaer A. Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas. Clin Nucl Med. 2002;27(9):622–4.

    Article  Google Scholar 

  35. Subhawong TK, Winn A, Shemesh SS, Pretell-Mazzini J. F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature. Skelet Radiol. 2017;46(9):1233–9.

    Article  Google Scholar 

  36. Staal HM, Dremmen MHG, Robben SGF, Witlox AMA, Rhijn LW. The use of whole-body MR imaging in children with HMO, an extended case study in two patients. Pediatr Ther. 2016;6:275.

    Article  Google Scholar 

  37. Doyle LA. Sarcoma classification: an update based on the 2013 World Health Organization classification of tumors of soft tissue and bone. Cancer. 2014;120:1763–74.

    Article  Google Scholar 

  38. The Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. J Bone Joint Surg Am. 2007;89:2113–23.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Blvd 99, 8200, Aarhus N, Denmark

    Anne Grethe Jurik & Mikkel Meng Mortensen

  2. Department of Radiology, Aarhus University Hospital, Palle Juul-Jensens Blvd 99, 8200, Aarhus N, Denmark

    Anne Grethe Jurik

  3. Department of Orthopedic Surgery, Aarhus University Hospital, Palle Juul-Jensens Blvd 99, 8200, Aarhus N, Denmark

    Peter Holmberg Jørgensen

Authors
  1. Anne Grethe Jurik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Holmberg Jørgensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mikkel Meng Mortensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne Grethe Jurik.

Ethics declarations

The study was not externally funded and none of the authors has conflicts of interests to disclose. Patient consent and approval from The Central Denmark Region Committees on Health Research Ethics was waived due to the retrospective quality control design of the study. The data extract was approved by the Data Protection Agency in the Central Denmark Region (protocol number 1–16–02-114-18).

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jurik, A.G., Jørgensen, P.H. & Mortensen, M.M. Whole-body MRI in assessing malignant transformation in multiple hereditary exostoses and enchondromatosis: audit results and literature review. Skeletal Radiol 49, 115–124 (2020). https://doi.org/10.1007/s00256-019-03268-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-019-03268-z

Keywords

Search

Navigation